EMED
emed.lv
Actively hiring
Web Development
Laboratory Equipment
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Medicīnas izstrādājumi +371 20111113 +371 20111113 +371 67542997 Uzdot jautājumu Ienākt GROZS [email protected] Latvija, GROZS +371 20111113 +371 20111113 +371 67542997 [email protected] +371 20111113 +371 20111113 +371 67542997 Izvēlne GROZS 0 PREČU KATALOGS Atpakaļ PREČU KATALOGS APĢĒRBS Atpakaļ APĢĒRBS…
News
At SXSW, Cuban and eMed CEO Draw Contrast Between Them and Other "Marketing" Companies
Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of the employer GLP-1 platform eMed Population Health, were at SXSW drawing a contrast between their approach to GLP-1 drugs and that of other direct-to-consumer companies. They also anno
Read more
Report
Tom Brady becomes 'chief wellness officer' at weight-loss shot company
The startup helps companies cover the high cost of GLP-1 drugs for employees
Read more
Report
Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform
Aon plc (NYSE: AON), a leading global professional services firm, today announced a strategic investment in eMed Population Health, Inc., an emerging leader in the delivery of GLP-1 programs. The partnership will enhance employer sponsored access to GLP-1
Read more
Report
Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her "undeniable ability to negotiate new partnerships."
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.